SCHEMBL6722798

SCHEMBL6722798

[CH2]Oc1ccc(CC)c(CC)c1CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14999441 0.80 TAAR1 (0.39)
SCHEMBL713109 0.78 MRGPRX4 (0.31)
Ethylene SCHEMBL27502363 0.78 GABRA1 (0.38)
SCHEMBL166573 0.78 GABRA1 (0.41)
SCHEMBL29619533 0.78 GABRA1 (0.41)
SCHEMBL444139 0.77 MRGPRX4 (0.30)
SCHEMBL3626144 0.77
Ammonia Solution, Strong SCHEMBL27539208 0.75 GABRA1 (0.39)
SCHEMBL29581467 0.75 NCEH1 (0.41)
SCHEMBL2697204 0.75 CTRC (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6673772-B2 INHIBITING THE ENZYMATIC ACTIVITY OF HIV PROTEASE SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) 2004-01-06 US disclosed
US-20020049165-A1 Novel dipeptide compounds and their use as medicines DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2002-04-25 US disclosed
EP-1157997-A1 NOVEL DIPEPTIDE COMPOUND AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2001-11-28 EP disclosed